The pump relaunch isn’t expected to contribute much to this year’s revenue, but could help Becton Dickinson reach its long-term financial goals.

Baxter has received 510(k) clearance from the Food and Drug Administration for its Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software, opening up a new market that J.P. Morgan analysts value at as much as $200 million.

• Smiths Medical’s recall of syringe infusion pumps has been categorized as a Class I event by the Food and Drug Administration.
• The company has received reports of seven serious injuries and one death related to software issues that could cause under- or over-infusion and delays in the delivery of critical medicines.

Three out of four infusion pumps used to deliver medications and fluids to patients have cybersecurity flaws, putting them at increased risk of being compromised by hackers, according to a new study by Palo Alto Networks' Unit 42 threat research service. 

Errors in the setup or management of some of Baxter International’s infusion pumps could result in overlooked blockages in the pumps, potentially leading to serious injury or even death, the devicemaker warned in a recent urgent safety communication.